WASHINGTON(AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according to ...
Tidmarsh says he was targeted after questioning a new fast-track drug approval program A separate lawsuit accuses Tidmarsh of 'revenge,' which he denies TUESDAY, Nov. 4, 2025 (HealthDay News) — The ...
Through our Venable FDA Pulse series, we provide insight into key developments within the Food and Drug Administration (FDA or the Agency), emerging trends, enforcement activity, and other topics ...
The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct WASHINGTON -- The head of the Food and Drug Administration’s drug center ...
The resignation came just days after he was placed on administrative leave while federal officials investigated accusations connected to a lawsuit involving a drug company and one of its investors.